Offered by: Nemours Children's
Study to Assess the Safety and Efficacy of Hectorol®(doxercalciferol capsules) in Pediatric Patients
The purpose of this study is to evaluate the possible risks and the effectiveness of an experimental study drug called Hectorol®, in patients ages 5–18 years old. Hectorol® is an inactive vitamin D2 that changes to an active vitamin D2 in the liver. Along with a hormone called "parathyroid hormone", it regulates the overall calcium concentration in the blood. In order to evaluate the possible risks and effectiveness of Hectorol®, a drug called Rocaltrol® will be used as a control compound in this study.
Children that have been diagnosed with Chronic Kidney Disease (stage 3 or 4) and who are between the ages of 5-18 years of age may be able to participate in the study.
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.